Oppenheimer cuts Spruce Biosciences shares target cut to $4 on trial results By Investing.com
© Reuters. On Thursday, Oppenheimer adjusted its outlook on Spruce Biosciences, Inc. (NASDAQ:SPRB), reducing the price target to $4 for ...
© Reuters. On Thursday, Oppenheimer adjusted its outlook on Spruce Biosciences, Inc. (NASDAQ:SPRB), reducing the price target to $4 for ...
© Reuters. Coinbase stock target raised as analyst expects robust Bitcoin ETF inflows JMP Securities analysts raised their price target ...
90min rounds up the latest transfer news, rumours and gossip circulating around the world...Manchester United and Chelsea are both 'very, very interested' ...
© Reuters. On Monday, Xcel Energy Inc. (NASDAQ:) received an upgrade in its stock rating by a Citi analyst, moving ...
© Reuters On Monday, BMO Capital Markets adjusted its price target on shares of Kroger Co . (NYSE:), the supermarket ...
Not long ago I pointed to a case where we could see the perfectly predictable outcomes of wage controls playing ...
China’s top leaders on Tuesday set an ambitious target for economic growth but they signaled only modest stimulus measures, not ...
© Reuters. On Friday, ACI Worldwide (NASDAQ:), a global provider of real-time electronic payment and banking solutions, saw its stock ...
© Reuters. On Friday, Deutsche Bank adjusted its outlook on New York Community Bancorp (NYSE:), reducing the stock price target ...
© Reuters On Wednesday, BMO Capital Markets adjusted its share price target for eBay (NASDAQ:), increasing it to $53.00 from ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.